Tevogen Bio leverages AI to revolutionize precision medicine, merging proprietary datasets with generative AI models. The company's approach focuses on transforming therapeutic applications from generalized to highly personalized treatments. AI's…
Spotlight Therapeutics aimed to innovate gene editing by combining CRISPR technology with a cell-specific delivery system similar to antibody-drug conjugates. The company failed to advance its therapies beyond laboratory experiments…
Jade Biosciences is set to present its innovative autoimmune therapies at major biotech conferences in March 2025, with appearances in Boston and Miami. The company will highlight JADE-001, focusing on…
Edesa Biotech focuses on innovation in biotech, particularly in developing the inflammatory treatment paridiprubart. Research and development saw a significant investment increase, exceeding $300,000, highlighting their commitment to healthcare advancements.…
Ascentage Pharma, a key player in the global pharmaceutical landscape, has recently secured an impressive $126.4 million through a U.S. IPO. This substantial funding is primarily earmarked for the advanced…
DynaCord is making waves in Baton Rouge by acquiring the former Unitech Training Academy building for a staggering $2.6 million. The purchase, finalized through Dynacord Holdings LLC, marks an exciting…